Obstet Gynecol. 1992 Apr;79(4):589-91.

Low-dose oral methotrexate as second-line therapy for persistent trophoblast after conservative treatment of ectopic pregnancy.

Bengtsson G, Bryman I, Thorburn J, Lindblom B.

Source

Department of Obstetrics and Gynecology, University of Göteborg, Sahlgrenska Hospital, Sweden.

Abstract

The aim of this study was to evaluate the efficacy of methotrexate as second-line treatment for ectopic pregnancy. Oral methotrexate was used in 15 patients with evidence of persistent trophoblast after conservative laparoscopic surgery for tubal pregnancy. The treatment was successful in 14 of 15 cases, and the mean time for decline of serum hCG to nonpregnant levels was 24 days. In the remaining case, hCG continued to rise. Side effects were noticed, even at a low dosage, but only in those subjects not receiving citrovorum rescue. As an alternative to a second operation, oral methotrexate appears to be an effective and well-tolerated therapy for persistent trophoblast.

PMID:: 1532446; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Ovid Technologies, Inc.

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy. [BJOG. 2001]
A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy.
Sowter MC, Farquhar CM, Petrie KJ, Gudex G. BJOG. 2001 Feb; 108(2):192-203.
Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. [Obstet Gynecol. 1991]
Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases.
Stovall TG, Ling FW, Gray LA, Carson SA, Buster JE. Obstet Gynecol. 1991 May; 77(5):749-53.
[Successful drug therapy of persistent ectopic pregnancy after tube-saving operation]. [Geburtshilfe Frauenheilkd. 1994]
[Successful drug therapy of persistent ectopic pregnancy after tube-saving operation].
Riederer M, Gulik L. Geburtshilfe Frauenheilkd. 1994 Jul; 54(7):423-5.
Review [Systemic methotrexate therapy of persistent trophoblast after tube saving surgery for extrauterine pregnancy]. [Gynakol Geburtshilfliche Runds...]
Review [Systemic methotrexate therapy of persistent trophoblast after tube saving surgery for extrauterine pregnancy].
Perucchini D, Schär G, Köchli OR, Fink D. Gynakol Geburtshilfliche Rundsch. 1995; 35(1):29-33.
Review Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. [Hum Reprod Update. 2008]
Review Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis.
Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ. Hum Reprod Update. 2008 Jul-Aug; 14(4):309-19. Epub 2008 Jun 2.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Low-dose oral methotrexate as second-line therapy for persistent trophoblast aft...
Low-dose oral methotrexate as second-line therapy for persistent trophoblast after conservative treatment of ectopic pregnancy.
Obstet Gynecol. 1992 Apr ;79(4):589-91.

PubMed
Flagellin acting via TLR5 is the major activator of key signaling pathways leadi...
Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells.
BMC Microbiol. 2004 Aug 23 ;4:33.

PubMed
Management strategies for gastroesophageal reflux disease.
Management strategies for gastroesophageal reflux disease.
J Gastroenterol Hepatol. 2004 Sep ;19 Suppl 3:S49-53.

PubMed
Autosomal dominant palmoplantar hyperkeratosis and sensorineural deafness in thr...
Autosomal dominant palmoplantar hyperkeratosis and sensorineural deafness in three generations.
J Med Genet. 1992 Jan ;29(1):50-2.

PubMed
High magnetic field induced charge density wave state in a quasi-one-dimensional...
High magnetic field induced charge density wave state in a quasi-one-dimensional organic conductor.
Phys Rev Lett. 2004 Aug 13 ;93(7):076406. Epub 2004 Aug 13 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: